INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 240 filers reported holding INSMED INC in Q3 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $980,862 | +21.3% | 38,846 | +1.4% | 0.01% | +14.3% |
| Q2 2023 | $808,552 | +20.8% | 38,320 | -2.4% | 0.01% | +16.7% |
| Q1 2023 | $669,298 | -11.2% | 39,255 | +4.0% | 0.01% | -14.3% |
| Q4 2022 | $753,925 | +7.7% | 37,734 | +16.2% | 0.01% | 0.0% |
| Q3 2022 | $700,000 | +10.2% | 32,479 | +0.8% | 0.01% | +16.7% |
| Q2 2022 | $635,000 | -15.6% | 32,223 | +0.7% | 0.01% | 0.0% |
| Q1 2022 | $752,000 | -10.6% | 31,998 | +3.6% | 0.01% | 0.0% |
| Q4 2021 | $841,000 | -1.2% | 30,892 | -0.1% | 0.01% | -14.3% |
| Q3 2021 | $851,000 | +6.8% | 30,914 | +10.4% | 0.01% | +16.7% |
| Q2 2021 | $797,000 | -21.1% | 28,010 | -5.5% | 0.01% | -33.3% |
| Q1 2021 | $1,010,000 | +3.1% | 29,654 | +0.8% | 0.01% | 0.0% |
| Q4 2020 | $980,000 | 0.0% | 29,430 | -3.5% | 0.01% | -10.0% |
| Q3 2020 | $980,000 | +58.6% | 30,485 | +35.8% | 0.01% | +11.1% |
| Q2 2020 | $618,000 | +93.7% | 22,452 | +12.7% | 0.01% | +80.0% |
| Q1 2020 | $319,000 | – | 19,926 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,054,713 | $49,839,000 | 3.76% |
| SENZAR ASSET MANAGEMENT, LLC | 788,936 | $7,778,909,000 | 1.70% |
| NEXTHERA CAPITAL LP | 168,700 | $1,663,000 | 1.44% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $2,169,000 | 1.04% |
| Orbimed Advisors | 4,158,600 | $41,004,000 | 0.43% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 667,848 | $6,585,000 | 0.37% |
| Rock Springs Capital Management LP | 497,500 | $4,905,000 | 0.36% |
| EMERALD ADVISERS, LLC | 630,159 | $6,213,000 | 0.30% |
| Virtus ETF Advisers LLC | 24,536 | $242,000 | 0.18% |
| Baker Brothers Advisors | 1,500,000 | $14,790,000 | 0.16% |